MURANO update: MRD, biological subsets & amp; safety analysis

MURANO (NCT02005471) is a Phase III randomized trial comparing the efficacy of venetoclax plus rituximab vs. standard chemoimmunotherapy of bendamustine plus rituximab in relapsed/refractory chronic l... Author: VJHemOnc Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts